Skip to main content Help with accessibility Skip to main navigation

Relugolix–estradiol–norethisterone acetate

Indication

Moderate to severe symptoms of uterine fibroids (NICE TA832)

NICE TA832 - Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids

Amber level 0

Brand:

Ryeqo

Nice TA:

832

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

1.1 Relugolix–estradiol–norethisterone acetate is recommended, within its marketing authorisation, as an option for treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.

Recommendation

LSCMMG Recommendation:

Amber level 0

Reason for decision:

Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Decisions of Lancashire local decision making groups

BwD
BP
CSR
EL
FW
GP
MB
WL
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
What do the colours mean?

Last Updated: 24 - Jan - 2023